Understanding the Ebola and Marburg virus proteins to develop better treatments
Computational and Biophysical Analysis of the Filovirus Matrix Protein System
This study is looking at a protein from the Ebola and Marburg viruses to understand how it works and interacts with other molecules, which could help find new treatments for these serious illnesses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Purdue University NIH-funded |
| Lab location | 1 site (West Lafayette, United States) |
| Project ID | NIH-10886721 on NIH RePORTER |
What this research studies
This research investigates the matrix protein VP40 of Ebola and Marburg viruses, which are responsible for severe hemorrhagic fevers with high mortality rates. By using advanced computational and biophysical methods, the team aims to understand how VP40 interacts with itself and other molecules, which is crucial for the virus's lifecycle. The study utilizes virus-like particles to observe these interactions outside of high-security labs, making it safer and more accessible. The goal is to uncover the fundamental mechanisms of VP40 to identify potential drug targets for treating these deadly viruses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of exposure to Ebola or Marburg viruses, including healthcare workers and researchers in endemic regions.
Not a fit: Patients who are not at risk of exposure to these viruses or those with no history of infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for Ebola and Marburg virus infections, potentially saving lives.
How similar studies have performed: Previous research on viral proteins has shown promise in understanding viral mechanisms and developing treatments, indicating that this approach could be successful.
Where this research is happening
West Lafayette, United States
- Purdue University — West Lafayette, United States (Active)
Researchers
- Principal investigator: Stahelin, Robert Virgil — Purdue University
- Study coordinator: Stahelin, Robert Virgil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.